Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes (SNOW)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Montreal Heart Institute
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Michel White, Montreal Heart Institute
ClinicalTrials.gov Identifier:
NCT01586442
First received: April 24, 2012
Last updated: April 28, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)